. 2020 Aug 20;12(9):913. doi: 10.3390/v12090913

Table 3.

Jember DENV serotypes and their clinical correlates.

Parameters	DENV Serotype (n = 61)				p-Value
Parameters	DENV-1 (n = 3)	DENV-2 (n = 3)	DENV-3 (n = 12)	DENV-4 (n = 43)	p-Value
Age, Median (IQR)	8	11	20	20	0.336 ^a
Age, Median (IQR)	(7–12.5)	(7.2–20)	(11.8–22.3)	(11.5–30.5)	0.336 ^a
Gender					0.143 ^b
Male	3	1	4	25
Female	0	2	8	18
Clinical manifestation					0.011 ^b,c
DF	0	1	10	33
DHF	3	2	2	10
Infection status					0.004 ^b,d
Primary	1	1	12	36
Secondary	2	2	0	6
Hematology, Median (IQR)
Platelet (×10³/µL)	20	73	185	143	0.008 ^a,e
Platelet (×10³/µL)	(15.5–20.5)	(53.5–86)	(118.8–194)	(76–227.5)	0.008 ^a,e
Hematocrit (%)	2.90	2.60	3.65	4.64	0.529 ^a
Hematocrit (%)	(2.65–3.25)	(2.50–3.20)	(2.90–4.60)	(2.95–8.50)	0.529 ^a
WBC (×10³/µL)	47.5	44.4	42.0	41.5	0.204 ^a
WBC (×10³/µL)	(43.2–47.8)	(41.6–45.2)	(38.3–45.6)	(38.6–45.1)	0.204 ^a

IQR, interquartile range. ^a Kruskall–Wallis test. ^b Pearson’s Chi-squared test. ^c Post-hoc Bonferroni: p = 0.112 (DENV-1—others), p = 1.000 (DENV-2—others), p = 1.000 (DENV-3 – others), p = 1.000 (DENV-4—others). ^d Post-hoc Bonferroni: p = 0.338 (DENV-1—others), p = 0.338 (DENV-2—others), p = 0.776 (DENV-3—others), p = 1.000 (DENV-4—others). ^e Post-hoc Dunn: p = 0.019 (DENV-1—others), p = 0.438 (DENV-2—others), p = 0.660 (DENV-3—others), p = 1.000 (DENV-4—others).